Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post Market Study to Evaluate the Chondrofix® Osteochondral Allograft Utilized for Treatment of Subjects With Cartilage Lesions in the Knee

NCT01410136 is registered in ClinicalTrials.gov with Zimmer Orthobiologics, Inc. as lead sponsor.

NCT NCT01410136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01410136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post Market Study to Evaluate the Chondrofix® Osteochondral Allograft Utilized for Treatment of Subjects With Cartilage Lesions in the Knee
Lead sponsor
Zimmer Orthobiologics, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2011
Completion date
March 31, 2014
Enrollment
29 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute cartilage injury, articular cartilage disorder, chronic cartilage injury, defect of articular cartilage, degeneration; articular cartilage